Table 3 Subgroup analysis of well-controlled type 2 diabetes in oral antidiabetic therapy versus early insulinization.

HbA1c

 < 9%

44

2.11 (0.99, 4.49)

0.054

2.10 (0.99, 4.48)

0.055

≥ 9%

182

1.11 (0.80, 1.56)

0.530

1.12 (0.80, 1.57)

0.496

Gender

Male

145

1.15 (0.79, 1.67)

0.460

1.16 (0.80, 1.69)

0.425

Female

81

1.53 (0.89, 2.63)

0.127

1.53 (0.89, 2.63)

0.128

Age

 < 40

55

0.93 (0.51, 1.71)

0.814

0.93 (0.50, 1.72)

0.817

≥ 40

171

1.42 (0.99, 2.02)

0.057

1.40 (0.98, 2.00)

0.066

BMI

< 30

186

1.30 (0.93, 1.81)

0.124

1.29 (0.93, 1.80)

0.133

≥ 30

40

1.19 (0.54, 2.61)

0.666

1.51 (0.65, 3.50)

0.339